In this issue:
- SCENT trial leads to first ever indication of flow diverter to treat challenging aneurysms
- Evidence in favour of DRG stimulation builds with new study
- Steven Levine: To treat or not to treat?
- Profile: Urs Fischer
Most read
Features
In this issue: